Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24745435 | 0.66 | CREBBP (0.37) | LMNAKMT2A | |
| SCHEMBL24745361 | 0.63 | LMNA (0.44) | LMNAKMT2A | |
| SCHEMBL31710566 | 0.60 | MPO (0.45) | LMNAKMT2A | |
| SCHEMBL31710557 | 0.58 | PDE4A (0.36) | — | |
| SCHEMBL110500 | 0.56 | L3MBTL1 (0.42) | LMNAKMT2A | |
| SCHEMBL24677739 | 0.53 | — | — | |
| SCHEMBL31488029 | 0.53 | ALDH1A1 (0.37) | LMNAKMT2A | |
| SCHEMBL16920690 | 0.53 | CREBBP (0.39) | — | |
| SCHEMBL24409056 | 0.52 | — | — | |
| SCHEMBL31755407 | 0.51 | ALDH1A1 (0.39) | LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022255888-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2022-12-08 | — | — | WO | disclosed |
| WO-2022253713-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2022-12-08 | — | — | WO | disclosed |